22.03.2025 11:44:00

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

Valuation always matters in investing. And sometimes you can find stocks that are especially great bargains.Three Motley Fool contributors believe they've done just that. Here's why they think Altimmune (NASDAQ: ALT), Moderna (NASDAQ: MRNA), and Pfizer (NYSE: PFE) are dirt cheap now, and why buying these value stocks could be a brilliant move.David Jagielski (Altimmune): If you want to swing for the fences, one underrated GLP-1 weight loss drug company you'll want to consider investing in right now is Altimmune. It's not the safest healthcare stock to own as there's no guarantee of how well its GLP-1 drug candidate, pemvidutide, will perform in late-stage trials, but its clinical results so far have been promising.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Analysen zu :be AG Inhaber-Aktmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

:be AG Inhaber-Akt 0,30 -66,67% :be AG Inhaber-Akt